These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30516924)

  • 1. The current status of renal cell carcinoma and prostate carcinoma grading.
    Delahunt B; Egevad L; Yaxley J; Samaratunga H
    Int Braz J Urol; 2018; 44(6):1057-1062. PubMed ID: 30516924
    [No Abstract]   [Full Text] [Related]  

  • 2. Updates in Histologic Grading of Urologic Neoplasms.
    Rice-Stitt T; Valencia-Guerrero A; Cornejo KM; Wu CL
    Arch Pathol Lab Med; 2020 Mar; 144(3):335-343. PubMed ID: 32101058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gleason and Fuhrman no longer make the grade.
    Delahunt B; Egevad L; Samaratunga H; Martignoni G; Nacey JN; Srigley JR
    Histopathology; 2016 Mar; 68(4):475-81. PubMed ID: 26266664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interobserver reproducibility of a grading system for chromophobe renal cell carcinoma.
    Pérez-Pedrosa A; Ortiz-Rey JA; Lorenzo-Mahía Y; Iglesias-Rodríguez B; Peteiro-Cancelo A; González-Carreró J
    Actas Urol Esp; 2013 Jun; 37(6):338-41. PubMed ID: 23058995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity.
    Amin MB; Smith SC; Agaimy A; Argani P; Compérat EM; Delahunt B; Epstein JI; Eble JN; Grignon DJ; Hartmann A; Hes O; Hirsch MS; Jimenez RE; Kunju LP; Martignoni G; McKenney JK; Moch H; Montironi R; Paner GP; Rao P; Srigley JR; Tickoo SK; Reuter VE
    Am J Surg Pathol; 2014 Jul; 38(7):871-4. PubMed ID: 24805860
    [No Abstract]   [Full Text] [Related]  

  • 6. [New approaches to the classification, grading, and prognosis of renal cell carcinoma].
    Moskvina LV; andreeva IuIu; Mal'kov PG; Frank GA
    Arkh Patol; 2014; 76(2):60-70. PubMed ID: 25051730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
    Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
    Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updates in Pathologic Staging and Histologic Grading of Renal Cell Carcinoma.
    Taneja K; Williamson SR
    Surg Pathol Clin; 2018 Dec; 11(4):797-812. PubMed ID: 30447842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [WHO classification 2016 and first S3 guidelines on renal cell cancer: What is important for the practice?].
    Moch H
    Pathologe; 2016 Mar; 37(2):127-33. PubMed ID: 26942728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis.
    Avulova S; Cheville JC; Lohse CM; Gupta S; Potretzke TA; Tsivian M; Thompson RH; Boorjian SA; Leibovich BC; Potretzke AM
    Eur Urol; 2021 Feb; 79(2):225-231. PubMed ID: 33172723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of simplified Fuhrman grading system in clear-cell renal cell carcinoma.
    Hong SK; Jeong CW; Park JH; Kim HS; Kwak C; Choe G; Kim HH; Lee SE
    BJU Int; 2011 Feb; 107(3):409-15. PubMed ID: 20804473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 1997 TNM classification of renal cell carcinoma revisited: the pendulum swings back.
    Sagalowsky AI
    Curr Opin Urol; 2002 Sep; 12(5):371-3. PubMed ID: 12172422
    [No Abstract]   [Full Text] [Related]  

  • 13. Urologic Pathology: Key Parameters from a Urologist's Perspective.
    Borchert A; Rogers CG
    Surg Pathol Clin; 2018 Dec; 11(4):893-901. PubMed ID: 30447847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.
    Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Srigley JR; Coughlin G; Dunglinson N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Yaxley J; Samaratunga H
    Histopathology; 2017 Dec; 71(6):918-925. PubMed ID: 28718911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The WHO/ISUP grading system for renal carcinoma].
    Moch H
    Pathologe; 2016 Jul; 37(4):355-60. PubMed ID: 27271258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and classification of renal cell carcinoma.
    Bostwick DG; Eble JN
    Urol Clin North Am; 1999 Aug; 26(3):627-35. PubMed ID: 10494293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comment to «Is a new classification of the Fuhrman grade in clear cell renal cell carcinomas feasible?»].
    López JI
    Actas Urol Esp; 2012 Jun; 36(6):359-60. PubMed ID: 22266256
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathology of renal cell carcinoma: recent developments.
    Shanks JH
    Clin Oncol (R Coll Radiol); 1999; 11(4):263-8. PubMed ID: 10473724
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal tumours: the new order.
    Delahunt B; Eble JN
    N Z Med J; 1998 Aug; 111(1072):307-9. PubMed ID: 9765626
    [No Abstract]   [Full Text] [Related]  

  • 20. Is histologic subtype a significant prognostic factor in renal cell carcinoma?
    Ramsey S; Aitchison M
    Nat Clin Pract Urol; 2005 Aug; 2(8):374-5. PubMed ID: 16474733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.